MONDE:PSEMonde Nissin Corp. Analysis
Data as of 2026-06-17 - not real-time
$62.15
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Mondelez (MDLZ) is trading at $62.15, comfortably above its 20‑day ($61.93), 50‑day ($60.38) and 200‑day ($58.92) simple moving averages, indicating a sustained bullish bias. The RSI sits near 53, suggesting neither overbought nor oversold conditions, while the MACD histogram has turned slightly negative but remains close to the signal line, reinforcing a tentative bullish stance. Volatility over the past 30 days is about 18%, and beta is near zero, implying limited market‑wide price swings. Fundamental metrics show a forward P/E of 18.35 versus a trailing P/E of 30.77, a dividend yield of 3.22% with a high payout ratio (~97%), and a DCF‑derived fair value of $25.83, leaving the current price significantly above intrinsic estimates. Revenue grew 8.2% year‑over‑year, supported by strong brand franchises and emerging‑market exposure, while operating margins hover around 9.3% and free cash flow remains healthy. However, the company carries $21.6 B of debt, yielding a debt‑to‑equity ratio of ~84%, which adds balance‑sheet pressure. Recent news highlights Mondelez’s focus on “elusive growth opportunities for 2026” and a “golden‑cross‑like” technical rally boosted by easing cocoa prices, underscoring both growth potential and short‑term price momentum.
Overall, the stock appears overvalued relative to its DCF estimate, yet the combination of solid cash generation, attractive dividend yield, and strategic growth initiatives provide a compelling case for a cautious hold. Investors should monitor debt levels, dividend sustainability, and any further macro‑commodity relief before committing to a larger position.
Overall, the stock appears overvalued relative to its DCF estimate, yet the combination of solid cash generation, attractive dividend yield, and strategic growth initiatives provide a compelling case for a cautious hold. Investors should monitor debt levels, dividend sustainability, and any further macro‑commodity relief before committing to a larger position.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above key moving averages indicating bullish trend
- Support level near $59.95 and resistance at $64.35
- High dividend payout ratio raises sustainability concerns
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- 8.2% revenue growth and expanding presence in emerging markets
- Favorable cocoa price environment supporting margin improvement
- Strong free cash flow to fund growth initiatives
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Current price far exceeds DCF fair value, suggesting valuation correction
- Robust brand portfolio and dividend yield provide defensive qualities
- Elevated debt level and near‑full payout ratio could pressure earnings
Key Metrics & Analysis
Financial Health
Revenue Growth8.20%
Profit Margin6.64%
P/E Ratio30.8
ROE10.16%
ROA3.43%
Debt/Equity83.79
P/B Ratio3.1
Op. Cash Flow$3.9B
Free Cash Flow$2.8B
Technical Analysis
TrendBullish
RSI53.0
Support$59.95
Resistance$64.35
MA 20$61.93
MA 50$60.38
MA 200$58.92
MACDBearish
VolumeStable
Fear & Greed Index92.13
Valuation
Fair Value$25.83
Target Price$67.21
Upside/Downside8.14%
GradeOvervalued
TypeGrowth
Dividend Yield3.22%
Risk Assessment
Beta-0.07
Volatility18.05%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.